首页> 美国卫生研究院文献>Elsevier Public Health Emergency Collection >Construction of a bovine-murine heteromyeloma cell line; Production of bovine monoclonal antibodies against rotavirus and pregnant mare serum gonadotrophin
【2h】

Construction of a bovine-murine heteromyeloma cell line; Production of bovine monoclonal antibodies against rotavirus and pregnant mare serum gonadotrophin

机译:牛-鼠异种骨髓瘤细胞系的构建;牛抗轮状病毒和母马血清促性腺激素的单克隆抗体的生产

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Bovine-murine heteromyeloma cell lines were prepared by fusing lymphoid cells from a bovine leukemia virus (BLV)-infected cow with mouse myeloma cells. Selection of hybrid cell colonies was based on the ratio of bovine and murine chromosomes, the presence of cell-surface immunoglobulins and growth characteristics. First-generation fusion partners were compared for fusion efficiency and the number of antigen-specific antibody-producing clones generated. Hybrid cell colonies that initially secreted antibodies were selected from first-generation heteromyelomas to function as second-generation fusion partners. Although fusion efficiencies for both generations did not differ, the second-generation heteromyelomas yielded a higher number of specific antibody-producing clones. Fusion of heteromyelomas with either lymph node cells or splenocytes indicated that fusion with lymph node cells results in a higher number of specific antibody-producing clones, whereas fusion efficiency was found to be higher with splenocytes. The optimal time intervals between the final booster injection and fusion were found to be 4 days for splenocytes and 7 days for lymph node cells. Finally, the characterization of bovine monoclonal antibodies against bovine rotavirus and pregnant mare serum gonadotrophin and their neutralizing capacities in vitro are described.
机译:通过将感染了牛白血病病毒(BLV)的牛的淋巴样细胞与小鼠骨髓瘤细胞融合来制备牛-鼠异种骨髓瘤细胞系。杂交细胞集落的选择基于牛和鼠染色体的比例,细胞表面免疫球蛋白的存在和生长特性。比较了第一代融合伴侣的融合效率和产生的产生抗原特异性抗体的克隆的数量。从第一代异源骨髓瘤中选择最初分泌抗体的杂种细胞集落,以充当第二代融合伴侣。尽管两代的融合效率没有差异,但是第二代异源骨髓瘤产生了更多的特异性抗体产生克隆。异种骨髓瘤与淋巴结细胞或脾细胞的融合表明与淋巴结细胞的融合导致更高数量的特异性抗体产生克隆,而发现与脾细胞的融合效率更高。最后一次加强注射和融合之间的最佳时间间隔是脾细胞为4天,淋巴结细胞为7天。最后,描述了针对牛轮状病毒和母马血清促性腺激素的牛单克隆抗体的表征及其体外中和能力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号